XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2020
Net Loss Per Share [Abstract]  
Net Loss Per Share (14) Net Loss Per Share:

The reconciliation of the net loss per share calculation is as follows:

For the three months ended

For the six months ended

June 30,

June 30,

($ in millions and shares in thousands, except per share amounts)

2020

2019

2020

2019

Net loss used for basic and diluted loss

per share:

Total basic net loss

attributable to Frontier common shareholders

$

(181)

$

(5,317)

$

(367)

$

(5,404)

Effect of loss related to dilutive stock units

-

-

-

-

Total diluted net loss

attributable to Frontier common shareholders

$

(181)

$

(5,317)

$

(367)

$

(5,404)

Basic loss per share:

Total weighted average shares and unvested restricted stock

awards outstanding - basic

104,988 

105,314 

105,029 

105,377 

Less: Weighted average unvested restricted stock awards

(463)

(1,196)

(592)

(1,390)

Total weighted average shares outstanding - basic

104,525 

104,118 

104,437 

103,987 

Basic net loss per share

attributable to Frontier common shareholders

$

(1.73)

$

(51.07)

$

(3.51)

$

(51.97)

Diluted loss per share:

Total weighted average shares outstanding - basic

104,525 

104,118 

104,437 

103,987 

Effect of dilutive stock units

-

-

-

-

Total weighted average shares outstanding - diluted

104,525 

104,118 

104,437 

103,987 

Diluted net loss per share

attributable to Frontier common shareholders

$

(1.73)

$

(51.07)

$

(3.51)

$

(51.97)

In calculating diluted net loss per common share for the three and six months ended June 30, 2020 and 2019, the effect of all common stock equivalents is excluded from the computation as the effect would be antidilutive.

Stock Options

For the three and six months ended June 30, 2020 and 2019, previously granted options to purchase 1,344 shares issuable under employee compensation plans were excluded from the computation of diluted earnings (loss) per share (EPS) for those periods because the exercise prices were greater than the average market price of our common stock and, therefore, the effect would be antidilutive.

Stock Units

At each of June 30, 2020 and June 30, 2019, we had 339,544 stock units issued under the Non-Employee Directors’ Deferred Fee Equity Plan (Deferred Fee Plan), the Non-Employee Directors’ Equity Incentive Plan (Directors’ Equity Plan), the 2013 Equity Incentive Plan and the 2017 Equity Incentive Plan. These securities have not been included in the diluted EPS calculation for the six months ended June 30, 2020 and 2019 because their inclusion would have an antidilutive effect. Compensation costs associated with the issuance of stock units were $0 million for each of the six months ended June 30, 2020 and 2019, respectively.